MK-677 (Ibutamoren)
MK-677 (Ibutamoren) is a research compound investigated for its activity as a ghrelin receptor (GHSR-1a) agonist. Its unique mechanism has made it an important tool in endocrine, metabolic, sleep physiology, and growth hormone axis research.
Scientific Background
MK-677 is studied for its ability to activate the growth hormone secretagogue receptor (GHSR-1a), the same receptor targeted by the endogenous hormone ghrelin. Researchers utilize this mechanism to investigate signaling pathways involved in growth hormone regulation, insulin-like growth factor-1 (IGF-1) physiology, appetite signaling, sleep architecture, and metabolic homeostasis.
Current research explores the interaction between ghrelin receptor activation, neuroendocrine signaling, body composition, skeletal muscle physiology, and recovery-related biological processes. Because the growth hormone axis plays a central role in metabolism and tissue maintenance, MK-677 continues to be an important compound for endocrine and metabolic research.
Why Researchers Study MK-677
Researchers utilize MK-677 to investigate:
- Ghrelin receptor (GHSR-1a) signaling
- Growth hormone axis physiology
- IGF-1 regulation
- Neuroendocrine signaling
- Appetite regulation pathways
- Sleep physiology research models
- Metabolic homeostasis
- Body composition and tissue biology
Research Specifications
- Precision capsule format
- Internal quality assurance review
- Supported by third-party analytical testing
- Fulfilled by the Rogue Compounds in-house team
